Business
Drawbacks of the TGA’s cannabis changes for listed pot stocks – Small Caps
Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses.
Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulators endorsement of the weed as an effective therapy that should be more freely available to the ailing masses.
But the path to the pharmacy is likely to be harder than they think, with an emerging supply glut pushing prices to record lows.
In an interim ruling this month, the Therapeutic Goods Administration (TGA) said it intended to downgrade low-dose c…
-
General22 hours agoZoe Daniel calls for election recount in Goldstein after final count gives Liberal Party’s Tim Wilson 260-vote lead
-
Noosa News21 hours ago‘Stranded’ Eddie the echidna thought to have swum from Bribie Island’s broken tip
-
Business12 hours agoAre your superannuation fees too high? APRA reveals latest industry medians
-
Business11 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025